Similar to the findings of previous studies [16, 18], USP22 was found to be expressed at higher levels in poorly differentiated cancer cell lines and cancer tissues and to correlate closely with HCC differentiation (Fig. 1). This evidence concerns the gene USP22 and hepatocellular carcinoma.